Instil Bio, Inc. (TIL)
↓ Download CSV- Sector Manufacturing
- Incorporated NY
- Fiscal year ends Dec 31
Key ratios (FY2025)
-62.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $138.0K | — |
| Operating Income | -$78.58M | -$73.54M | -$159.17M | -$226.46M | -$155.56M | -$33.64M | — |
| Net Income | -$71.37M | -$74.14M | -$156.09M | -$223.18M | -$156.79M | -$37.74M | — |
| EPS (Diluted) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | — |
| Total Assets | $203.52M | $263.57M | $325.63M | $482.13M | $609.98M | $319.01M | — |
| Total Liabilities | $89.66M | $94.13M | $99.80M | $118.52M | $54.78M | $26.64M | — |
| Shareholders' Equity | $113.87M | $169.44M | $225.83M | $363.61M | $555.20M | -$39.60M | -$6.89M |
| Cash & Equivalents | $6.64M | $8.80M | $9.20M | $43.72M | $37.59M | $241.71M | — |
| Operating Cash Flow | -$36.62M | -$55.70M | -$82.03M | -$180.16M | -$122.14M | -$29.62M | — |
| Capital Expenditures | — | $0 | $20.66M | $84.59M | $57.83M | $50.82M | — |
| Shares Outstanding | 6.78M | 6.53M | 6.50M | 6.50M | 129.03M | 20.59M | — |